Real World Study of Oral Upadacitinib Tablets to Assess Adverse Events and Change in Disease Activity in Adolescent and Adult Chinese Participants With Atopic Dermatitis
Clinical trial NCT05959083 · COMPLETED
Trial details
- NCT number
- NCT05959083
- Sponsor
- AbbVie
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2023-08-18
- Primary completion
- 2026-05-07
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.